Kegeles, Lawrence S.
New York State Psychiatric Institute · Columbia University
22 papers on CoChatORCID 0000-0002-8083-1167
Most cited papers
- Verified
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 1,020
- Verified
Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum
Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism
Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment
Cited by 569
- Verified
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 565
- Verified
Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum
Martinez, D., Gil, R., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Kegeles, L., Talbot, P., Evans, S., Krystal, J., et al. (2005) · Biological Psychiatry
Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes
Cited by 445
- Verified
Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 437
- Verified
Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
Rodriguez, C. I., Kegeles, L. S., Levinson, A., Feng, T., Marcus, S. M., Vermes, D., Flood, P., & Simpson, H. B. (2013) · Neuropsychopharmacology
Obsessive-Compulsive Spectrum DisordersTreatment of Major Depression
Cited by 386
- Verified
Decreased Regional Brain Metabolism After ECT
Nobler, M. S., Oquendo, M. A., Kegeles, L. S., Malone, K. M., Campbell, C., Sackeim, H. A., & Mann, J. J. (2001) · American Journal of Psychiatry
Electroconvulsive Therapy StudiesTreatment of Major Depression
Cited by 330
- Verified
Positron Emission Tomography of Regional Brain Metabolic Responses to a Serotonergic Challenge and Lethality of Suicide Attempts in Major Depression
Oquendo, M. A., Placidi, G. P. A., Malone, K. M., Campbell, C., Keilp, J., Brodsky, B., Kegeles, L. S., Cooper, T. B., Parsey, R. V., Van Heertum, R. L., et al. (2003) · Archives of General Psychiatry
Suicide and Self-Harm StudiesTreatment of Major Depression
Cited by 313
- Verified
Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [11C]raclopride
Urban, N. B. L., Kegeles, L. S., Slifstein, M., Xu, X., Martinez, D., Sakr, E., Castillo, F., Moadel, T., O'Malley, S. S., Krystal, J. H., et al. (2010) · Biological Psychiatry
Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes
Cited by 223
- Verified
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects
Abi-Dargham, A., van de Giessen, E., Slifstein, M., Kegeles, L. S., & Laruelle, M. (2009) · Biological Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 213
- Verified
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Slifstein, M., Javitt, D. C., Lieberman, J. A., Abi-Dargham, A., & Girgis, R. R. (2014) · Molecular Psychiatry
Schizophrenia research and treatmentAdvanced MRI Techniques and Applications
Cited by 205
- Verified
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
Milak, M. S., Proper, C. J., Mulhern, S. T., Parter, A. L., Kegeles, L. S., Ogden, R. T., Mao, X., Rodriguez, C. I., Oquendo, M. A., Suckow, R. F., et al. (2016) · Molecular Psychiatry
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 144
- Verified
Investigation of Cortical Glutamate–Glutamine and γ-Aminobutyric Acid in Obsessive–Compulsive Disorder by Proton Magnetic Resonance Spectroscopy
Simpson, H. B., Shungu, D. C., Bender, J., Mao, X., Xu, X., Slifstein, M., & Kegeles, L. S. (2012) · Neuropsychopharmacology
Obsessive-Compulsive Spectrum DisordersAdvanced MRI Techniques and Applications
Cited by 138
- Verified
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
Parsey, R. V., Oquendo, M. A., Zea-Ponce, Y., Rodenhiser, J., Kegeles, L. S., Pratap, M., Cooper, T. B., Van Heertum, R., Mann, J. J., & Laruelle, M. (2001) · Biological Psychiatry
Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression
Cited by 133
- Verified
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide
Abi-Dargham, A., Kegeles, L. S., Zea-Ponce, Y., Mawlawi, O., Martinez, D., Mitropoulou, V., O'Flynn, K., Koenigsberg, H. W., Van Heertum, R., Cooper, T., et al. (2004) · Biological Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 128
- Verified
Striatal and extrastriatal dopamine release measured with PET and [18F] fallypride
Slifstein, M., Kegeles, L. S., Xu, X., Thompson, J. L., Urban, N., Castrillon, J., Hackett, E., Bae, S. ‐., Laruelle, M., & Abi‐Dargham, A. (2010) · Synapse
Neurotransmitter Receptor Influence on BehaviorMedical Imaging Techniques and Applications
Cited by 115
- Verified
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial
Javitt, D. C., Carter, C. S., Krystal, J. H., Kantrowitz, J. T., Girgis, R. R., Kegeles, L. S., Ragland, J. D., Maddock, R. J., Lesh, T. A., Tanase, C., et al. (2018) · JAMA Psychiatry
Schizophrenia research and treatmentTreatment of Major Depression
Cited by 100
- Verified
Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder
Kantrowitz, J. T., Dong, Z., Milak, M. S., Rashid, R., Kegeles, L. S., Javitt, D. C., Lieberman, J. A., & John Mann, J. (2021) · Translational Psychiatry
Treatment of Major DepressionNeuroscience and Neuropharmacology Research
Cited by 100
- Verified
Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial
Milak, M. S., Rashid, R., Dong, Z., Kegeles, L. S., Grunebaum, M. F., Ogden, R. T., Lin, X., Mulhern, S. T., Suckow, R. F., Cooper, T. B., et al. (2020) · JAMA Network Open
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 63
- Verified
Rapid Resolution of Obsessions After an Infusion of Intravenous Ketamine in a Patient With Treatment-Resistant Obsessive-Compulsive Disorder
Rodriguez, C. I., Kegeles, L. S., Flood, P., & Simpson, H. B. (2011) · The Journal of Clinical Psychiatry
Obsessive-Compulsive Spectrum DisordersTreatment of Major Depression
Cited by 59
- Verified
Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography
van Berckel, B. N. M., Kegeles, L. S., Waterhouse, R., Guo, N., Hwang, D.-R., Huang, Y., Narendran, R., Van Heertum, R., & Laruelle, M. (2006) · Neuropsychopharmacology
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 43
- Verified
Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT2A/2C serotonin agonist
Zea-Ponce, Y., Kegeles, L. S., Guo, N., Raskin, L., Bakthavachalam, V., & Laruelle, M. (2002) · Nuclear Medicine and Biology
Radiopharmaceutical Chemistry and ApplicationsNeurotransmitter Receptor Influence on Behavior
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free